Search filters

List of works by Ashley M Regazzi

A phase II trial of durvalumab and tremelimumab in metastatic, non-urothelial carcinoma of the urinary tract

scientific article published on 31 December 2020

Clinical and Genomic Characterization of Bladder Carcinomas With Glandular Phenotype

scientific article published in 2022

Complete response as an intermediate end point in patients receiving salvage systemic therapy for urothelial carcinoma.

scientific article published on 2 October 2014

Impact of the number of prior lines of therapy and prior perioperative chemotherapy in patients receiving salvage therapy for advanced urothelial carcinoma: implications for trial design.

scientific article published on 9 June 2014

Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma

scientific article published on 11 April 2022

Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma.

scientific article published on 10 June 2014

Phase II study of everolimus in metastatic urothelial cancer

scientific article

Phase II study of gemcitabine, carboplatin, and bevacizumab in patients with advanced unresectable or metastatic urothelial cancer.

scientific article published on 22 January 2013

The high incidence of vascular thromboembolic events in patients with metastatic or unresectable urothelial cancer treated with platinum chemotherapy agents.

scientific article

The safety and efficacy of single-agent pemetrexed in platinum-resistant advanced urothelial carcinoma: a large single-institution experience

scientific article published on 6 April 2015